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ABSTRACT 
Objective: The present study is carried out to know the mitigating role of zinc (Zn) and / or iron (Fe) supplementation on cadmium (Cd) induced 
toxicity in rats with special reference to metallothionein (MT) protein.  
Methods: Wistar strain male albino rats were treated orally with Cd at a dose of 1/10th of LD50
Results: A significant (P < 0.05 level) elevation in LPO levels with decreased activity levels of GST and GPx were observed during Cd intoxication. 
With Zn and Fe supplementation, a significant reversal in the above said parameters were observed. MT protein levels were significantly elevated in 
the test tissues during Cd treatment and also after supplementation with Zn and / or Fe. Maximum MT protein synthesis was observed in 30d rat 
kidney under combined supplementation of both Zn and Fe.  
 / 48h (i. e. 22.5 mg/kg) for 7, 15 and 30 days (d) long 
sojourn. 15d Cd treated rats were then subjected to trace element supplementations of Zn (12mg/kg) and Fe (40mg/kg) individually and in 
combination for another 7, 15 and 30d time intervals. After specific time intervals, rats were decapitated and tissues like liver and kidney were 
isolated. The vital oxidative stress enzymes such as GST and GPx were assayed by using the standard methods in the test tissues. LPO levels were 
also measured by using the standard protocol. MTs, the metal binding proteins which are the first line of defense against Cd toxicity were quantified 
by using the standard methods in the test tissues.  
Conclusion: The present study focuses on the mitigating role of trace elements Zn and Fe in reducing the Cd body burden from the selected tissues 
of rat. Supplementation with Zn and / or Fe envisages the therapeutic role of trace elements in combating the heavy metal, Cd insult. 
Keywords: Cadmium, Oxidative stress enzymes, Zinc and iron supplementation, Metallothionein, Liver, Kidney, Rat. 
 
INTRODUCTION 
Environmental pollution is a global problem and is common to both 
developed as well as developing countries. This pollution was 
caused by numerous chemicals, xenobiotics, heavy metals etc. 
Among the heavy metals, Cadmium (Cd) is one of the most toxic, 
non- essential heavy metal with many industrial uses that can 
contribute to a well-defined spectrum of diseases in animal models 
as well as in humans [1, 2].  
Over the past two centuries, anthropogenic and industrial activities 
have led to high emissions of Cd into the environment at 
concentrations significantly exceeding those originating from 
natural sources [3]. Cd has an estimated elimination half-life period 
of 20-30 years in the human body [4] and is highly cumulative, 
especially in the liver and kidney [5 - 8]. The main sources of Cd are 
storage batteries, electroplating, pigments, plastics, fertilizer 
industries and cigarette smoking.  
It is an ubiquitous toxic metal and induces oxidative damage by 
disturbing the prooxidant – antioxidant balance in the tissues [9]. Cd 
is readily distributed in tissues after exposure and interferes with 
intracellular signaling network and gene regulation at multiple 
levels and induces lipid peroxidation (LPO). Lipid peroxides that 
accumulate due to LPO are known to be harmful to cells and tissues 
and inhibit the antioxidant system of the cells [10, 11]. As a result of 
this inhibition, the electron transport chain becomes highly reduced, 
electrons are transferred directly to available oxygen and lead to 
enhanced formation of reactive oxygen species (ROS) [12]. ROS may 
lead to increase oxidative stress in tissues, cellular damage, 
peroxidation of membrane lipids and loss of membrane bound 
enzymes [13, 14], which might result in histological changes and 
physiological damage to different organs [15, 8, 16, 3]. Intake of Cd 
results in consumption of glutathione (GSH) and protein binding 
sulfhydral groups and subsequently the levels of free radicals such 
as hydrogen peroxide, hydroxide and superoxide are increased [17].  
Sulfhydral – rich, metal binding protein, Metallothionein (MT) may 
function in a manner similar to GSH. Wherein MT provides an 
intracellular ‘nucleophilic sink’ to trap free radicals, electrophiles 
and alkylating agents. MT’s is a class of low molecular weight (6-
7kDa), cysteine rich and transition metal binding proteins. MT’s 
occur throughout the animal kingdom and are also found in higher 
plants, eukaryotic microorganisms and in some prokaryotes [18 - 
21]. MT’s have the capacity to bind heavy metals through the thiol 
group of its cysteine residues. A large amount of subsequent work 
has shown MT to serve in many cell types in the management of 
essential divalent metal cations, to interfere with the toxic effects of 
xenobiotics, heavy metals, free radicals and to serve as a regulator of 
specific transcription factors. Cells that contain an excess amount of 
MT are resistant to Cd toxicity [22, 23].  
The complex inter-relationships between Cd and some essential 
trace elements have not been elucidated. Several essential trace 
elements like zinc (Zn), iron (Fe), selenium (Se) and copper (Cu) 
participate in controlling various metabolic and signaling pathways. 
Among the trace elements Zn and Fe are essential for maintenance 
of life and health. Zn is an essential trace metal with numerous 
functions in biological systems. Zn controls several enzymes of 
intermediary metabolism, DNA and RNA synthesis, gene expression, 
immunocompetence and plays a significant role in homeostasis of 
hormones. Zn also takes part in the defense against excessive 
amounts and following damage of certain metals, and it does so 
through the interaction with metallothionein. It has been noted that 
Zn has a relationship with many enzymes in the body and can 
prevent cell damage through activation of the antioxidant defense 
system [24, 25]. Fe plays an essential role in many biological 
processes and it is important to maintain iron concentration within 
its narrow normal range. Fe supplementation reduces Cd retention 
and Cd induced anemia during fast growth in young rats [26]. In 
vitro studies suggests that there is a competition for transport 
mechanism between Cd and some essential trace elements like Zn 
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and Cu [27], Fe [28] in rats, Zn and Se in Japanese quails [29] and 
calcium in suckling rats [30]. Hence, in the present study Zn and Fe 
were chosen as trace element supplements.  
MATERIALS AND METHODS 
Chemicals 
Cadmium as cadmium chloride (CdCl2), zinc as zinc chloride (ZnCl2), 
and iron as ferric chloride (FeCl3
Animals 
) were purchased from Merck 
(Dormstadt, Germany). All other chemicals which were used in the 
present study were obtained from the standard chemical companies 
like Sigma Chemical Co. (St Louis, Mo, USA) and SD Fine Chemicals. 
The chemicals used in this study were of the highest purity.  
Three months old Wistar strain male albino rats weighing 180 ± 20g 
were chosen for the present study. The animals were obtained from 
Sri Venkateswara Traders, Bangalore, Karnataka, India and were 
kept in stainless-steel mesh cages, housed under standard 
laboratory conditions (23 ± 20 
Experimental design 
C, 50 ± 20% relative humidity, 12h 
light - dark cycle) with Standard rat chow (Sai Durga feeds and 
foods, Bangalore, India) and drinking water ad libitum. The rats 
were acclimatized to the laboratory conditions for 10 days. The 
protocol and animal use has been approved by the Institutional 
Animal Ethics Committee (Resol. No.10(ii) / a / CPCSCA / IAEC / 
SVU / AUR-JO dt 22-12-2008), Sri Venkateswara University, 
Tirupati, Andhra Pradesh, India. 
After acclimatization, the rats were divided into two groups, namely 
control and experimental. Control rats received only de-ionised 
water without Cd. The experimental rats were treated with Cd as 
CdCl2 at a dose of 1/10th LD50
Isolation of tissues 
 /48h i. e. 22.5 mg / Kg body weight 
over a period of 7, 15 and 30 days (d) time intervals. Then the 15d 
Cd treated rats were divided into three groups. Group I received 
supplementation of Zn (12mg / Kg) for 7, 15 and 30d. Group II 
received Fe supplementation (40 mg / Kg) and Group III animals 
were supplemented with both Zn and Fe at the above said doses for 
7, 15 and 30d long sojourn.  
After specific time intervals, the control and experimental rats were 
decapitated and tissues such as liver and kidney were quickly 
isolated under ice cold conditions and weighed to their nearest mg 
using Shimadzu electronic balance. After weighing, tissues were 
immediately used for the assay of oxidative stress enzymes like GST, 
GPx, the levels of LPO and MT protein quantification.  
Assay of oxidative stress enzymes 
Lipid peroxidation (LPO) 
The LPO was determined by the TBA method of Ohkawa et al., [31]. 
The tissues were homogenized in 1.5% KCl (20% W/V). To 1 ml of 
tissue homogenate 2.5 ml of 20% TCA was added and the contents 
were centrifuged at 3,500g for 10 minutes (min) and the precipitate 
was dissolved in 2.5 ml of 0.05M sulphuric acid. To this, 3 ml of 
thiobarbituric acid (TBA) was added and the samples were kept in a 
hot water bath for 30 min. The samples were cooled and 
malonaldehyde (MDA) was extracted with 4 ml of n-butanol and the 
colour was read at 530 nm in a UV spectrophotometer (Hitachi U-
2000) against the reagent blank. Trimethoxy pentane (TMP) was 
used as the external standard. Values are expressed in µ moles of 
MDA formed / g tissue / hr. 
Glutathione – S – transferase (GST) (EC: 2.5.1.18) 
GST activity was measured with its conventional substrate 1-chloro, 
2, 4-dinitro benzene (CDNB) at 340 nm as per the method of Habig 
et al., [32]. The tissues were homogenized in 50 mM Tris-Hcl buffer 
pH 7.4 containing 0.25 M sucrose and centrifuged at 4000 g for 15 
min at 40C and the supernatant was again centrifuged at 16,000 g for 
1 hour (hr) at 40
Glutathione peroxidase (GPx) (EC: 1.11.1.9) 
C. The pellet was discarded and the supernatant was 
used as the enzyme source. The reaction mixture in a volume of 3 ml 
contained 2.4 ml of 0.3 M potassium phosphate buffer pH 6.9, 0.1 ml 
of 30 mM CDNB, 0.1 ml of 30 mM glutathione and the appropriate 
enzyme source. The reaction was initiated by the addition of 
glutathione and the absorbance was read at 340 nm against the 
reagent blank and the activity was expressed as μ moles of thioether 
formed / mg protein / min. 
GPx was determined by a modified method of Flohe and Gunzler 
[33] at 370C. 5% (W/V) of tissue homogenate was prepared in 50 
mM phosphate buffer (pH 7.0) containing 0.1 mM EDTA. The 
homogenates were centrifuged at 10,000 g for 10 min at 40C in cold 
centrifuge. The resulting supernatant was used as enzyme source. 
The reaction mixture consisted of 500 μl of phosphate buffer, 100μl 
of 0.01 M GSH (reduced form), 100 μl of 1.5 mM NADPH and 100μl of 
GR (0.24 units). The 100μl of tissue extract was added to the 
reaction mixture and incubated at 370
Then 50 μl of 12 mM t-butyl hydroperoxide was added to 450 μl of 
tissue reaction mixture and measured at 340 nm for 180 s. The 
molar extinction coefficient of 6.22 X10
C for 10 min.  
3 M cm-1
Metallothionein quantification 
 was used to 
determine the activity. The enzyme activity was expressed in µ 
moles of NADPH oxidized / mg protein / min. 
The initial isolation of MT protein from liver and kidney 
homogenates were carried out by following Fowler et al., [34]. The 
clear supernatants thus obtained from liver and kidney 
homogenates was again subjected to the purification process. 
Supernatant fractions of each tissue was applied to a column of 
Sephadex, G-75 (5 x 50 cm) equilibrated with 10 mM Tris-HCl buffer 
(pH 7.4). Further purification of MT protein was carried out by Ion 
exchange chromatography using DEAE-32CELLULOSE by following 
the method of Overnell and Coombs [35]. Purified MT protein 
quantification was performed by using Lowry et al., [36]. 
Estimation of protein content 
Protein content of the tissues was estimated by the method of Lowry 
et al., [36]. 1 % (W/V) homogenates of the tissues were prepared in 
0.25 M ice cold sucrose solution. To 0.5 ml of homogenate, 1 ml 10% 
TCA was added and the samples were centrifuged at 1000g for 15 
min. Supernatant was discarded and the residues were dissolved in 
1 ml of 1N sodium hydroxide. To this 4 ml of alkaline copper reagent 
was added followed by 0.4 ml of the folin-phenol reagent (1:1folin: 
H2
Data analysis 
O). The color was measured at 600 nm in a UV spectrophotometer 
(Hitachi U-2000) against reagent blank. The protein content of the 
tissues was calculated using a protein (BSA) standard graph. 
The data was subjected to statistical analysis such as mean, standard 
deviation and Analysis of variance (ANOVA) using standard 
statistical software, SPSS (version 16) software. All values are 
expressed as Mean ± SD of 6 individual samples. Significant 
differences were indicated at P < 0.05 level. 
RESULTS 
Results revealed that LPO levels were significantly (P < 0.05 level) 
increased in both liver and kidney of Cd treated rats over control 
(Fig. 1). The LPO levels were increased with the time intervals of Cd 
treatment compared to control and were maximum for 30d kidney 
(71.083 ± 2.113 µ moles of MDA formed /g tissue / hr). After 
supplementation with Zn and / or Fe, the LPO levels were 
progressively decreased at all time periods in both the test tissues. 
Maximum depletion was observed in Zn and Fe combined 
supplemented 30d rat kidney (38.791±1.278 µ moles of MDA 
formed /g tissue / hr).  
GST activity levels also showed a progressive decrement at all time 
intervals of Cd treatment with a maximum depletion in 30d rat liver 
(15.146 ± 0.715 µ moles of thioether formed / mg protein / min). 
Further supplementation with both Zn and Fe, the GST activity 
reached to normalcy in 30d rat kidney (30.299 ± 0.288 µ moles of 
thioether formed / mg protein / min) suggesting the protective role 
of trace elements Zn and Fe (Fig. 2). 
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Fig. 1: The levels of LPO (µ moles of MDA formed / g tissue / hr) 
in liver and kidney of Cd treated rats before after 
supplementation with Zn and / or Fe. 
 
 
Fig. 2: GST activity levels (µ moles of thioether formed / mg 
protein / min) in liver and kidney of Cd treated rats before after 
supplementation with Zn and / or Fe. 
 
GPx activity levels also showed a significant decrease at all time 
intervals of Cd treatment with a maximum decrease in 30d kidney 
(0.822 ± 0.097 µ moles of NAPDPH oxidized / mg protein / min). 
However, the aforesaid Cd inhibited GPx activity levels were 
markedly elevated in both the test tissues after supplementation 
with the trace elements Zn and Fe both individually as well as in 
combination (Fig. 3). The combination of Zn and Fe at 30d as 
supplement was more effective in elevating the GPx activity levels in 
the liver tissue of rats (1.266 ± 0.008 µ moles of NAPDPH oxidized / 
mg protein / min). 
 
 
Fig. 3: GPx activity levels (µ moles of NADPH oxidized / mg 
protein / min) in liver and kidney of Cd treated rats before after 
supplementation with Zn and / or Fe. 
 
Quantification of MT protein content was carried out in both liver 
and kidney tissues of control rats. Cd treated as well as Zn and / or 
Fe supplementations to the 15d Cd treated rats. Results revealed 
that MT levels were profoundly increased in both liver and kidney of 
Cd treated rats at all time intervals when compared to the controls. 
30d Cd treated rat kidney showed maximum synthesis of MT protein 
(15.095 ± 0.454 μg / g wet weight of the tissue) followed by 30d Cd 
treated rat liver (12.013 ± 0.282 μg / g wet weight of the tissue) at 
all the treatment time intervals (Fig. 4).  
 
 
Fig. 4: MT Protein (µ g / g wet weight of the tissue) levels in the 
selected tissues of Cd treated rats. 
 
After supplementation with Zn and / or Fe to 15d Cd treated rats, 
the MT levels were highly elevated in both liver and kidney during 
all the time intervals. Maximum MT protein synthesis was found in 
30d rat kidney under combined supplementation of Zn and Fe 
(17.481 ± 0.313 μg / g wet weight of the tissue) (Fig. 7). Moderate 
increment in the synthesis of MT protein was found in 30d Zn 
supplemented rat kidney and liver (17.141 ± 0.363 μg / g wet weight 
of the tissue and 14.827 ± 0.313 μg / g wet weight of the tissue 
respectively). While in the 30d Fe alone supplementation, both the 
test tissues showed low level of increment in MT protein content 
(16.579 ± 0.342 μg / g wet weight of the tissue in kidney and 13.886 
± 0.324 μg / g wet weight of the tissue in liver) than the other modes 
of supplementation (Fig. 5 - 7). 
  
 
Fig. 5: MT Protein (µ g / g wet weight of the tissue) levels in the 
tissues of Cd treated rats after supplemented with Zn. 
 
 
Fig. 6: MT Protein (µ g / g wet weight of tissue) levels in the 
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Fig. 7: MT Protein (µ g / g wet weight of tissue) levels in the 
tissues of Cd treated rats after supplementation with Zn and Fe. 
 
From the present investigation, it is clear that the MT protein 
synthesis was high in the combined supplementation of Zn and Fe 
than the individual supplementation of Zn and Fe. The elevation in 
MT synthesis indicates its role in detoxification of heavy metal Cd 
and also in scavenging of ROS, which were generated by Cd burden 
in the liver and kidney tissues. 
DISCUSSION 
The results of the present study revealed that Cd induces significant 
alterations in the levels of LPO and certain oxidative stress enzymes 
status in liver and kidney of male albino rat at all specific time 
intervals. These activities were progressively reversed after using 
trace element supplements like Zn and / or Fe.  
Several mechanisms have been proposed for Cd induced various 
abnormalities, but none have yet been defined explicitly. Disruption 
of a variety of biochemical processes have been proposed rather 
than a single mechanism responsible for Cd toxicity. Recently, 
oxidative stress has been reported as one of the important 
mechanisms of toxic effects of Cd. Cd induced oxidative stress shows 
the significant impact on membrane, DNA and an antioxidant 
defense system of the cell [37, 38].  
In our study, the levels of LPO were significantly increased in the 
liver and kidney of Cd treated rats in a time-dependent manner, 
suggesting that long-term exposure to Cd profoundly causes LPO 
thereby resulting in oxidative damage. Several studies also 
demonstrated an increased LPO levels in the liver and kidney of test 
animals during Cd treatment [39 - 44]. LPO has been reported to 
enhance tissue water content, permeability and several fatty acids 
and lysophospholipids are released, leading to changes in 
biomembrane microviscosity and kinetic properties. This changes 
the ultrastructure and integrity of membrane causing loss of 
membrane bound enzymes [10, 45, 11]. Further, it has been 
suggested that during Cd treatment, potentially harmful byproducts 
are generated including ROS in the organisms [43]. ROS thus 
generated by Cd intoxication reacts with membrane lipids and 
causes LPO and finally it may lead to cell death [46, 47].  
The reduced GST activity in the tissues may be due to over 
consumption of the enzyme GST to escape from the toxicity of 
peroxides under Cd insult. GST catalyzes the reaction of the thiol (-
SH) group of GSH with electrophilic reagents such as those 
generated by microsomal metabolism of xenobiotics, thereby 
neutralizing their electrophilic sites and rendering the products 
more water soluble [48]. The decrease in GST activity might have 
resulted with Cd effect on GSH because of its high affinity to this 
molecule where a sulfhydryl acid, an amino acid and two carboxylic 
acid groups, as well as two peptide linkages represent reactive sites 
for metals. Reactions of metals with glutathione might lead to either 
the formation of complexes or the oxidation of glutathione. The 
decreased GST activity in the test tissues is in agreement with El-
Missiry and Shalaby [49] in Cd treated rat brain and testis. 
Moreover, the decrease in the activity of each of them would induce 
increased free radicals thus injuring the corresponding tissues. GPx 
is a hydrogen peroxide degrading enzyme. Its activity was 
significantly decreased in both liver and kidney under Cd body 
burden at all time intervals. The decreased GPx activity in the 
current study may be due to impairment in GSH homeostasis in liver 
and kidney tissues. As a result of this, liver and kidney tissue damage 
might have occurred under Cd insult. Recently Ognjanovic et al., [9], 
Messaoudi et al., [50] and Obaiah and Usha Rani [51] also reported 
decreased GPx activity in the liver and kidney tissues of rats under 
Cd stress. It may be due to either free radical dependent inactivation 
of enzyme or depletion of its co-substrate i. e., GSH and NADPH in 
the Cd treated rat liver and kidney. Cd administered rat tissues 
showed decreased GSH content due to over utilization by the cells in 
the tissues. Due to non-bioavailability of GSH under Cd burden, 
decrement in the activity levels of GPx has also been observed in 
experimental tissues. Depletion of GSH may render in GPx 
inactivation and / or less activity [52].  
Studies by Fariss [53] have shown that the free radical scavengers 
and antioxidants are useful in protecting the tissues against Cd 
toxicity. Zn and Fe are the two important free radical scavengers 
[54] which play an important role in many biological functions 
including pro-oxidant and antioxidant status. In the present study, 
rats treated to Cd for 15 days were challenged with Zn and / or Fe to 
know whether these antioxidants have ability to mitigate Cd-
induced oxidative stress or not. The time point, 15 days were 
selected because, a complete deterioration of antioxidant status was 
observed in the liver and kidney of these rats treated to Cd. 
Surprisingly, the results of the present study indicates that 
supplementation of Zn or Fe or a combination of both Zn and Fe 
reverses the Cd induced oxidative stress in the liver and kidney of 
rats. Supplementation of Zn and Fe either individually or in 
combination, inhibited the formation of MDA in the liver and kidney 
of experimental animals. A significant reduction in the MDA was 
observed in the liver tissue of Zn supplemented Cd treated rats 
during 15 and 30 days time intervals (Table - VI). Based on the 
available literature it is clearly evident that most of the antioxidant 
enzymes become inactive by Cd exposure due to the direct binding 
of the Cd to enzyme active sites if they contains –SH group or by 
displacement of metal co-factors from their active sites [55, 17]. 
Further, it has been suggested that Zn and Fe supplements sustain 
the bioavailability of the essential trace elements thereby playing a 
role in displacement of Cd from the metal binding sites of enzymes, 
which in turn may help in bringing down the enzymatic antioxidants 
to normal and functional [56 - 59, 50, 60]. Recently, it has also been 
reported that Zn and Fe provide protection against Cd induced 
alteration through the induction of MT either directly or indirectly 
[61, 62] and activation of antioxidant defense system and in turn 
decrease the ROS generation [63 - 65]. These findings are confirmed 
that the trace elements (Zn and Fe) may reduce the Cd mediated 
tissue damage by blocking the oxidative chain reaction and 
suppressing the formation of LPO products such as MDA. Our results 
in the present investigation are in consonance with earlier studies 
[66 - 68, 59].  
In recent years, Cd has been recognized as one of the most toxic 
environmental and industrial pollutant due to its ability to induce 
severe alterations in various organs and tissues. One of tissue 
protection mechanisms against these toxic effects of Cd is MT 
synthesis [69, 21]. MTs are cytoplasmic proteins that sequester 
certain divalent metal cations and are considered as primary cellular 
defense against the toxic transition metal Cd. In the present 
investigation, MT protein quantification was carried out in both liver 
and kidney tissues of the male albino rat. MT protein levels were 
significantly increased in Cd treated rats over controls in the present 
study which indicates that Cd exposure induces MT synthesis in liver 
and kidney of rats. Our results are in consonance with the earlier 
reports of Haki Kara et al., [70] and Kukner et al., [69]. Previous 
studies of Lu et al., [71, 72], Chaumont et al., [73], Chen et al., [74] 
and Kukner et al., [69] revealed that the MT synthesis was high in Cd 
exposed workers. In another study, Kang [22] also reported that the 
cells contain an excess amount of MT that are resistant to Cd toxicity.  
To protect from heavy metal toxicity, organisms synthesizes more 
MT protein as it involves in the homeostasis of essential metal ions 
(Zn and Fe), detoxification of heavy metals (Hg and Cd), protection 
against oxidative damage through scavenging of ROS, cell 
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levels of MT protein synthesis were found in liver and kidney of rats 
during supplementation with essential trace elements like Zn and Fe 
over Cd treated as well as control rats. However, the occurrence of 
MT protein in the control rats in the present study indicates the 
ubiquitous nature in the organism of non-polluted environments [80 
- 83, 23]. Increased synthesis of MT has been thought to produce 
antioxidant effect against ROS in Cd and other heavy metal 
intoxications [84]. 
More synthesis of MT protein was found in kidney tissue than liver 
in all the modes of supplementation with Zn and / or Fe as well as Cd 
treatment. A notable induction of MT protein under Cd over load in 
the kidney of the present study suggests that kidney might serve as a 
“Critical Organ” to Cd toxicity. The present data shows the low level 
of hepatic MT concentration than renal MT concentrations. Many 
reports suggested that ingestion of Cd is absorbed and transported 
to plasma where it binds with albumin to form Cd-albumin complex 
[85] via pulmonary or gastro intestinal route. Cd-albumin is 
absorbed predominantly by the liver and Cd is released from the 
albumin in the liver tissue. The released Cd induces synthesis of MT 
in the liver and most of the Cd is bound to MT [86, 87]. As the liver is 
the first site of Cd bioaccumulation, where Cd binds with MT [88], 
the Cd-MT complex transported to kidney tissue might have caused 
MT increase in the renal tissue. Several authors also reported that 
MT protein is induced in liver under Cd intoxication, as it is the first 
site of accumulation of Cd and plays a vital role in the formation of 
Cd-MT complex and from there the complex is transported to kidney 
[85, 74, 89, 90]. 
It is believed that MT plays an important role in Zn metabolism and 
is popularly known as reservoir of Zn. Zn-MT rescues the function of 
Cd - substituted tramtrack, a zinc finger transcription factor [91, 92]. 
When Cd displaces Zn in tramtrack, this protein loses DNA binding 
activity. Incubating Zn - MT with Cd tramtrack in vitro allows the 
exchange of Cd and Zn, with the transcription factor regaining its 
DNA binding activity. Hence, Zn-MT may rescue zinc finger proteins 
from inactivation by other metals. Fe is another essential trace 
element that plays an important role in MT and hemoglobin 
synthesis and also in redox reactions. It is an essential nutrient to 
almost all organisms [93, 94] and plays an essential role in biological 
processes. Fe induces MT either indirectly or by way of antioxidant 
response elements [28, 95]. In the present study, the supplemented 
Fe influenced the expression of MT in both the test tissues of rat 
under experimentation. The mechanism of MT protein induction by 
Fe is not elucidated. 
Quantification of MT protein revealed that the kidney tissue showed 
more expression of MT than the liver tissue under Zn and / or Fe 
supplementation at all the time intervals of experimentation. 
Yasutake and Hirayama [96] reported that the supplementary Zn 
and / or Fe enhances MT turnover in the kidney than liver, although 
the mechanisms of such processes are not understood at present. 
However, our studies suggest that the increase of MT protein level in 
both the test tissues is probably mediated by the differential 
expression of MT gene. Interestingly, supplemented Zn and / or Fe 
was found to elevate the MT protein expression in the liver and 
kidney tissues of Cd treated rats, providing further evidence of the 
ameliorative effects of Zn and / or Fe supplementation against Cd 
induced stress response in Wistar strain male albino rats. It is well 
known that Zn and / or Fe provides protection against Cd induced 
alterations through the induction of MT either directly or indirectly 
[97, 62, 98], activation of antioxidant defense system and decreases 
the ROS generation [63, 64, 65].  
From the MT studies, it is clear that when Cd treated rats were 
subjected to Zn and / or Fe supplementation, the MT proteins 
provides protection against Cd induced oxidative stress and toxicity 
in the liver and kidney tissues. Based on the overall discussion it 
may be concluded that the mixture of Zn and Fe supplementation 
was more effective in the MT protein synthesis as well as in reducing 
the Cd body burden from the tissues than individual 
supplementation of Zn and Fe.  
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